FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4564811000001108: Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1963151000001116 Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1963161000001118 Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Is a Sirolimus 2mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Is pack of Rapamune 2mg tablets (Wyeth Laboratories) false Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has active ingredient Sirolimus false Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has AMP Rapamune 2mg tablets (Wyeth Laboratories) true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Sirolimus true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rapamune 2mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start